Literature DB >> 29791828

Diagnosis and Management of the Antiphospholipid Syndrome.

David Garcia1, Doruk Erkan1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29791828     DOI： 10.1056/NEJMra1705454

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  106 in total

1.  Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.

Authors:  María Del Carmen Zamora-Medina; Andrea Hinojosa-Azaola; Carlos A Nuñez-Alvarez; Angel Gabriel Vargas-Ruiz; Juanita Romero-Diaz
Journal:  Clin Rheumatol       Date:  2018-12-04       Impact factor: 2.980

2.  Comparison of patients with transient and sustained increments of antiphospholipid antibodies after acute ischemic stroke.

Authors:  Jun Sang Yoo; Young Seo Kim; Hyun Young Kim; Hyuk Sung Kwon; Seong-Ho Koh; Sung Hyuk Heo; Bum Joon Kim; Cheryl D Bushnell; Dae-Il Chang
Journal:  J Neurol       Date:  2021-02-06       Impact factor: 4.849

Review 3.  Anticoagulating patients with high-risk acquired thrombophilias.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

4.  Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity.

Authors:  William E Ruff; Carina Dehner; Woo J Kim; Odelya Pagovich; Cassyanne L Aguiar; Andrew T Yu; Alexander S Roth; Silvio Manfredo Vieira; Christina Kriegel; Olamide Adeniyi; Melissa J Mulla; Vikki M Abrahams; William W Kwok; Ruth Nussinov; Doruk Erkan; Andrew L Goodman; Martin A Kriegel
Journal:  Cell Host Microbe       Date:  2019-06-18       Impact factor: 21.023

5.  [Decompensated heart failure as a result of a systemic disease].

Authors:  B Greiner; K Remde; H-M Lorenz; R Max
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-04-11       Impact factor: 0.840

6.  Prevalence of antiphospholipid antibodies among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Andrea Cervi; James Demetrios Douketis
Journal:  Intern Emerg Med       Date:  2019-04-01       Impact factor: 3.397

7.  Acute Myocardial Infarction Involving Left Main Artery in a Patient with Antiphospholipid Syndrome.

Authors:  Wei-Hsiang Wang; Yen-Chou Chen; Ming-Hsiung Hsieh
Journal:  Acta Cardiol Sin       Date:  2019-11       Impact factor: 2.672

8.  Increased Adhesive Potential of Antiphospholipid Syndrome Neutrophils Mediated by β2 Integrin Mac-1.

Authors:  Gautam Sule; William J Kelley; Kelsey Gockman; Srilakshmi Yalavarthi; Andrew P Vreede; Alison L Banka; Paula L Bockenstedt; Omolola Eniola-Adefeso; Jason S Knight
Journal:  Arthritis Rheumatol       Date:  2020-01       Impact factor: 10.995

9.  Recurrent venous thromboembolism after discontinuation of rivaroxaban therapy in a patient with antiphospholipid syndrome.

Authors:  Shusuke Yagi; Seiichi Nishiyama; Toshio Abe; Masataka Sata
Journal:  BMJ Case Rep       Date:  2019-01-10

Review 10.  Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders.

Authors:  Saion Chatterjee; John D Pauling
Journal:  Clin Rheumatol       Date:  2020-09-21       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.